Yonkenafil-d7
Yonkenafil-d7 (Tunodafil-d7) is deuterium labeled Yonkenafil.
Product Specifications
Product Name Alternative
Tunodafil-d7
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Solubility
10 mM in DMSO
Smiles
O=C1N=C(C2=C(OCC)C=CC(S(=O)(N3CCN(CC3)CC)=O)=C2)NC4=C1C(C)=CN4C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H]
Molecular Formula
C24H26D7N5O4S
Molecular Weight
494.66
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1350764-01 0.02 mg (E-Coli)
Recombinant Vibrio vulnificus Putative reductase VV1_2829 (VV1_2829)
Ask
View Details 
MBS1350764-02 0.02 mg (Yeast)
Recombinant Vibrio vulnificus Putative reductase VV1_2829 (VV1_2829)
Ask
View Details 
MBS1350764-03 0.1 mg (E-Coli)
Recombinant Vibrio vulnificus Putative reductase VV1_2829 (VV1_2829)
Ask
View Details MBS1350764-04 0.1 mg (Yeast)
Recombinant Vibrio vulnificus Putative reductase VV1_2829 (VV1_2829)
Ask
View Details MBS1350764-05 0.02 mg (Baculovirus)
Recombinant Vibrio vulnificus Putative reductase VV1_2829 (VV1_2829)
Ask
View Details MBS1350764-06 0.02 mg (Mammalian-Cell)
Recombinant Vibrio vulnificus Putative reductase VV1_2829 (VV1_2829)
Ask
View Details